Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4844112

Brc1cnc2[nH]c(-c3ccc(OCCNCc4ccco4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
CHEK2 O96017 1/20 0.37
HDAC3 O15379 9/20 0.37
HDAC4 P56524 9/20 0.37
HDAC1 Q13547 9/20 0.37
HDAC7 Q8WUI4 9/20 0.37
HDAC2 Q92769 9/20 0.37
HDAC10 Q969S8 9/20 0.37
HDAC11 Q96DB2 9/20 0.37
HDAC8 Q9BY41 9/20 0.37
HDAC6 Q9UBN7 9/20 0.37
HDAC9 Q9UKV0 9/20 0.37
HDAC5 Q9UQL6 9/20 0.37
HPGD P15428 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839051 0.92 CHEK2 (0.36) ALDH1A1CHEK2HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL4842803 0.87 KMT2A (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL4843563 0.85 ALDH1A1 (0.41) ALDH1A1CHEK2HPGDMEN1KMT2A
Trifluoroacetic Acid SCHEMBL4843965 0.85 DRD2 (0.39) ALDH1A1CHEK2HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL4844131 0.84 HDAC6 (0.39) ALDH1A1CHEK2HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL4837229 0.84 KDM4E (0.40) ALDH1A1HDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL4840541 0.84 HTR5A (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL4840737 0.83 HDAC6 (0.44) CHEK2HDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL4842215 0.83 HDAC6 (0.41) CHEK2HDAC6MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL4837280 0.83 CDK4 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 ALDH1A1 1489/4885CHEK2 309/4885HDAC3 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.